Clinical Characteristics of Patients and Factors Associated with Switching Biologics in Asthma [Corrigendum]

Abstract

Matsumoto-Sasaki M, Simizu K, Suzuki M, et al. J Asthma Allergy. 2022;15:187–195 On page 187, the second author’s name Kaoruko Simizu should read Kaoruko Shimizu. Read the original article

Keywords

• aspirin-exacerbated respiratory disease
• asthma
• biologics
• comorbidities
• eosinophilic chronic rhinosinusitis